Discovery of a Series of Cyclohexylethylamine-Containing Protein Farnesyltransferase Inhibitors Exhibiting Potent Cellular Activity (original) (raw)
Peptidomimetic inhibitors of farnesyltransferase with high in vitro activity and significant cellular potency
Luisa Diomede
Bioorganic & Medicinal Chemistry Letters, 2007
View PDFchevron_right
Potent, non-thiol inhibitors of farnesyltransferase
Scott Mosser
Bioorganic & Medicinal Chemistry Letters, 1998
View PDFchevron_right
A novel class of highly potent, selective, and non-peptidic inhibitor of ras farnesyltransferase (FTase)
Jin-ho Lee
Bioorganic & Medicinal Chemistry Letters, 2001
View PDFchevron_right
Inhibition of human tumor cell growthIn vitro andIn vivo by a specific inhibitor of human farnesyltransferase: BIM-46068
Gilles Favre
International Journal of Cancer, 1999
View PDFchevron_right
Potent and Selective Non-Cysteine-Containing Inhibitors of Protein Farnesyltransferase
badr Saeed
Journal of Medicinal Chemistry, 1998
View PDFchevron_right
Farnesyltransferase Inhibitors: Overview of their Action and Role in Solid Malignancy Therapy
Alfredo Cesario
Letters in Drug Design & Discovery, 2005
View PDFchevron_right
CA1A2X-competitive inhibitors of farnesyltransferase as anti-cancer agents
Charles Omer
Trends in Pharmacological Sciences, 1997
View PDFchevron_right
Inhibition of human tumor cell growthin vivo by an orally bioavailable inhibitor of human farnesyltransferase, BIM-46228
Gilles Favre
International Journal of Cancer, 2001
View PDFchevron_right
Nonfarnesylated tetrapeptide inhibitors of protein farnesyltransferase
Yuval Reiss
The Journal of biological chemistry, 1991
View PDFchevron_right
Potent and Selective Farnesyl Transferase Inhibitors
Juozas Domarkas
Journal of Medicinal Chemistry, 2004
View PDFchevron_right
Comparison of Cytotoxic Activity of L778123 as a Farnesyltranferase Inhibitor and Doxorubicin against A549 and HT-29 Cell Lines
Soodabeh Davaran
Advanced pharmaceutical bulletin, 2013
View PDFchevron_right
Time-Dependent Inhibition of Protein Farnesyltransferase by a Benzodiazepine Peptide Mimetic
Robert Roskoski
Biochemistry, 2001
View PDFchevron_right
Inhibitors of farnesyl:protein transferase—A possible cancer chemotherapeutic
Daniele Leonard
1996
View PDFchevron_right
Novel Conformationally Extended Naphthalene-Based Inhibitors of Farnesyltransferase
Yves Lelievre
Journal of Medicinal Chemistry, 1997
View PDFchevron_right
RPR 130401, a Nonpeptidomimetic Farnesyltransferase Inhibitor with in Vivo Activity
Patrick Mailliet
Annals of the New York Academy of Sciences, 1999
View PDFchevron_right
Inhibition of farnesyltransferase with A-176120, a novel and potent farnesyl pyrophosphate analogue
David Arendsen
European Journal of Cancer, 2000
View PDFchevron_right
Synthesis, Biochemical, and Cellular Evaluation of Farnesyl Monophosphate Prodrugs as Farnesyltransferase Inhibitors
Torben Borchert, Patricia Mathieu
Journal of Medicinal Chemistry, 2007
View PDFchevron_right
Potent, Cell Active, Non-Thiol Tetrapeptide Inhibitors of Farnesyltransferase
Veeraswamy Manne
Journal of Medicinal Chemistry, 1996
View PDFchevron_right
Apoptotic and Cytostatic Farnesyltransferase Inhibitors Have Distinct Pharmacology and Efficacy Profiles in Tumor Models
Chiang Yu
Cancer Research, 2004
View PDFchevron_right
C-Terminal Modifications of Histidyl- N -benzylglycinamides To Give Improved Inhibition of Ras Farnesyltransferase, Cellular Activity, and Anticancer Activity in Mice
Barbara Gibbs, Scott Bur
Journal of Medicinal Chemistry, 1997
View PDFchevron_right
Sepp-Lorenzino L, Ma Z, Rands E, Kohl NE, Gibbs JB, Oliff A, Rosen NA peptidomimetic inhibitor of farnesylprotein transferase blocks the anchorage-dependent and -independent growth of human tumor cell lines. Cancer Res 55: 5302-5309
Laura Sepp-lorenzino
Cancer Research
View PDFchevron_right
Phenol-derived CVFM analog inhibitors of Ras Farnesyltransferase possessing cellular in vitro activity 1
anna ramunno
European Journal of Medicinal Chemistry, 1998
View PDFchevron_right
Farnesyltransferase inhibitors versus Ras inhibitors
Charles Omer
Current Opinion in Chemical Biology, 1997
View PDFchevron_right
Preclinical antitumor activity of BMS-214662, a highly apoptotic and novel farnesyltransferase inhibitor
Veeraswamy Manne
Cancer research, 2001
View PDFchevron_right
Farnesyltransferase inhibitors: promises and realities
Channing Der
Current Opinion in Pharmacology, 2002
View PDFchevron_right
Solid-phase synthesis and pharmacological evaluation of a library of peptidomimetics as potential farnesyltransferase inhibitors: an approach to new lead compounds
Philippe Chavatte
European Journal of Medicinal Chemistry, 2006
View PDFchevron_right
Novel and selective imidazole-containing biphenyl inhibitors of protein farnesyltransferase
Steven Muchmore
Bioorganic & Medicinal Chemistry Letters, 2003
View PDFchevron_right
Ras farnesylation as a target for novel antitumor agents: Potent and selective farnesyl diphosphate analog inhibitors of farnesyltransferase
Dinesh Patel
Drug Development Research, 1995
View PDFchevron_right